Hepatitis C virus and neurological damage.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  World Journal of Hepatology

• Publication date

  2016-04-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.4254/wjh.v8.i12.545PMID 27134702PMCID PMC4840160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-alcoholic fatty liver disease: The diagnosis and management

  2015cited by this paper
• Mechanisms of distal axonal degeneration in peripheral neuropathies.

  2015cited by this paper
• Informative gene network for chemotherapy-induced peripheral neuropathy

  2015cited by this paper
• Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds

  2015cited by this paper
• Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

  2015cited by this paper
• Extrahepatic manifestations in chronic hepatitis C virus carriers

  2015cited by this paper
• Non-alcoholic fatty liver disease: The diagnosis and management.

  2015cited by this paper
• Biomarkers for virus-induced hepatocellular carcinoma (HCC).

  2014cited by this paper
• Docking Studies of Pakistani HCV NS3 Helicase: A Possible Antiviral Drug Target

  2014cited by this paper
• Hepatitis C virus-associated neuropathy accompanied by eosinophilic vasculitis and granuloma formation.

  2014cited by this paper
• Diagnosis and treatment of chronic acquired demyelinating polyneuropathies

  2014cited by this paper
• Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia

  2014cited by this paper
• HCV-Related Central and Peripheral Nervous System Demyelinating Disorders

  2014cited by this paper
• Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

  2014cited by this paper
• Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

  2013cited by this paper
• Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

  2013cited by this paper
• Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy

  2013cited by this paper
• Hepatitis C virus-induced vasculitis: therapeutic options

  2013cited by this paper
• Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.

  2012cited by this paper
• Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment

  2012cited by this paper
• Hepatitis C virus infects the endothelial cells of the blood-brain barrier.

  2012cited by this paper
• Depressive and anxiety disorders in chronic hepatitis C patients: reliability and validity of the Patient Health Questionnaire.

  2012cited by this paper
• Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.

  2012cited by this paper
• The cryoglobulinaemias.

  2012cited by this paper
• Hepatitis C virus and the brain

  2012cited by this paper
• A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

  2012cited by this paper
• HCV-Related Nervous System Disorders

  2012cited by this paper
• A Case of Acute Disseminated Encephalomyelitis Associated with Hepatitis C Virus Infection

  2012cited by this paper
• Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine

  2012cited by this paper
• Central nervous system vasculitis and polyneuropathy as first manifestations of hepatitis C.

  2012cited by this paper
• Hepatitis C virus–associated polyarteritis nodosa

  2011cited by this paper
• Metabolic alterations and chronic hepatitis C: treatment strategies

  2011cited by this paper
• Cerebral Glucose Utilisation in Hepatitis C Virus Infection-Associated Encephalopathy

  2011cited by this paper
• Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence

  2011cited by this paper
• Neuropsychological alterations in hepatitis C infection: the role of inflammation.

  2011cited by this paper
• Clinicopathologic correlates of hepatitis C virus in brain: A pilot study

  2011cited by this paper
• Hepatitis C Virus Infection and Increased Risk of Cerebrovascular Disease

  2010cited by this paper
• Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

  2010cited by this paper
• A Review of Sleep Disturbance in Hepatitis C

  2010cited by this paper
• Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy

  2010cited by this paper
• Hepatitis C virus infection of neuroepithelioma cell lines.

  2010cited by this paper
• Psychiatric care of the patient with hepatitis C: a review of the literature.

  2010cited by this paper
• Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

  2010cited by this paper
• Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection

  2010cited by this paper
• Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity

  2010cited by this paper
• Apolipoprotein B‐associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti‐viral agents interferon‐alpha and ribavirin

  2009cited by this paper
• Systemic Autoimmune Diseases in Patients with Hepatitis C Virus Infection: Characterization of 1020 Cases (The HISPAMEC Registry)

  2009cited by this paper
• Visualizing hepatitis C virus infections in human liver by two-photon microscopy.

  2009cited by this paper
• The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research

  2009cited by this paper
• Transverse myelitis associated to HCV infection.

  2009cited by this paper
• Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

  2009cited by this paper
• Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

  2009cited by this paper
• Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries

  2009cited by this paper
• Interferon regulatory factor‐3 activation, hepatic interferon‐stimulated gene expression, and immune cell infiltration in hepatitis C virus patients

  2008cited by this paper
• Hepatitis C Virus Neuroinvasion: Identification of Infected Cells

  2008cited by this paper
• A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies*

  2008cited by this paper
• Primary hepatocytes as targets for Hepatitis C virus replication

  2008cited by this paper
• Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.

  2008cited by this paper
• In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion

  2008cited by this paper
• Extrahepatic manifestations of hepatitis C virus infection.

  2008cited by this paper
• HCV-related autoimmune and neoplastic disorders: the HCV syndrome.

  2007cited by this paper
• Severe recurrent myelitis in patients with hepatitis C virus infection

  2007cited by this paper
• Mitochondrial complex III deficiency in a case of HCV related noninflammatory myopathy

  2007cited by this paper
• Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV‐positive, HCV‐negative patients

  2006cited by this paper
• Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population

  2006cited by this paper
• A case of vacuolar myopathy during the course of chronic hepatitis C.

  2006cited by this paper
• Leukoencephalopathy as a rare complication of hepatitis C infection

  2006cited by this paper
• Central nervous system changes in hepatitis C virus infection.

  2006cited by this paper
• Thyroid Disorders in Chronic Hepatitis C Virus Infection

  2006cited by this paper
• Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases.

  2006cited by this paper
• Psychiatric management of the hepatitis C patient

  2006cited by this paper
• Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients

  2006cited by this paper
• Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.

  2005cited by this paper
• Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

  2005cited by this paper
• Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

  2005cited by this paper
• Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.

  2005cited by this paper
• Neuropsychiatric Adverse Effects of Interferon-α

  2005cited by this paper
• Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors

  2005cited by this paper
• Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study

  2005cited by this paper
• Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy.

  2004cited by this paper
• Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

  2004cited by this paper
• The blood-brain barrier: an overview: structure, regulation, and clinical implications.

  2004cited by this paper
• A gene atlas of the mouse and human protein-encoding transcriptomes.

  2004cited by this paper
• Hepatitis C virus infection and the brain

  2004cited by this paper
• Silent Celiac Disease in Chronic Hepatitis C: Impact of Interferon Treatment on the Disease Onset and Clinical Outcome

  2004cited by this paper
• Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.

  2004cited by this paper
• West Nile virus: crossing the blood-brain barrier

  2004cited by this paper
• Recurrent demyelinating myelitis associated with hepatitis C viral infection.

  2004cited by this paper
• A Potential Hidden Source of Hepatitis C Infection Among Noninjecting Drug Users

  2003cited by this paper
• Pubcrawler: www.pubcrawler.ie

  2003cited by this paper
• Cerebral vasculitis in a patient with HCV-related type II mixed cryoglobulinemia.

  2003cited by this paper
• Non‐enveloped HCV core protein as constitutive antigen of cold‐precipitable immune complexes in type II mixed cryoglobulinaemia

  2003cited by this paper
• Transverse myelitis associated with chronic hepatitis C.

  2003cited by this paper
• Psychiatric disorders among veterans with hepatitis C infection.

  2002cited by this paper
• Search for Hepatitis C Virus Negative-Strand RNA Sequences and Analysis of Viral Sequences in the Central Nervous System: Evidence of Replication

  2002cited by this paper
• Evidence for a cerebral effect of the hepatitis C virus.

  2001cited by this paper
• Acute disseminated encephalomyelitis associated with hepatitis C virus infection.

  2001cited by this paper
• The cryoglobulins: an overview

  2001cited by this paper
• Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature.

  2000cited by this paper
• Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

  2000cited by this paper

• Association between hepatitis C virus infection and cognitive decline in seniors: further evidence from Taiwan.

  2026cites this paper
• Divergent Inflammatory Profiles but No Predictive Biomarkers of Psychiatric Sequelae After Viral Infection: A 12-Month Cohort Study.

  2026cites this paper
• Association of viral RNAs in the choroid plexus with bipolar disorder and schizophrenia and evidence for the hepatitis C virus involvement in neuropathology

  2025cites this paper
• Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).

  2025cites this paper
• Underestimated virus impaired cognition-more evidence and more work to do

  2025cites this paper
• Guillain-Barré syndrome associated with hepatitis C virus: A case series and literature review

  2025influential citation
• Prevalence and risk factors of hepatitis B and C in Bahawalpur: a hospital-based study.

  2025cites this paper
• Mitochondrial Disruption in Viral‐Mediated Neuronal Injury: A Mechanistic Perspective

  2025cites this paper
• Environmental factors and their impact on chronic pain development and maintenance.

  2024cites this paper
• Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder

  2024cites this paper
• Underlying Factors Predisposing to Viral‐Induced Neurological Diseases

  2024cites this paper
• Extrahepatic Manifestations of Chronic Hepatitis C Virus: Review of the Literature.

  2024cites this paper
• The Prevalence of Depression and Its Potential Link to Liver Fibrosis in Patients Diagnosed With Chronic Hepatitis C Virus Infection Prior to the Initiation of Direct-Acting Antiviral Treatment

  2024cites this paper
• Blood‐borne viruses and neurological manifestations: An overview

  2024cites this paper
• Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases

  2024cites this paper
• Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study

  2024cites this paper
• Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals

  2024cites this paper
• Neurological Complications caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights.

  2023cites this paper
• Liposome-Mediated Anti-Viral Drug Delivery Across Blood–Brain Barrier: Can Lipid Droplet Target Be Game Changers?

  2023cites this paper
• Association of Cognitive Impairment With Chronic Viral Hepatitis Among Older Adults in Taiwan.

  2023cites this paper
• Cognitive Performance in Asymptomatic Elderly People with Hepatitis C: The Role of Education

  2023cites this paper
• Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.

  2023cites this paper
• PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study.

  2023cites this paper
• Structural and metabolic changes in the central nervous system in women with HIV/HCV co-infection

  2022cites this paper
• Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview

  2022cites this paper
• At the Root of 3 “Long” Diseases: Persistent Antigens Inflicting Chronic Damage on the Brain and Other Organs in Gulf War Illness, Long-COVID-19, and Chronic Fatigue Syndrome

  2022cites this paper
• Infectious diseases and cognition: do we have to worry?

  2022cites this paper
• Neurological Paraneoplastic Syndromes: the Early Diagnosis of Lung Cancer

  2022cites this paper
• Microbial Infections Are a Risk Factor for Neurodegenerative Diseases

  2021cites this paper
• Deciphering the molecular pathogenesis behind neurological manifestations of SARS-CoV-2 and drug repurposing, a systems biology approach

  2021cites this paper
• Polyneuropathy following COVID-19 infection: the rehabilitation approach

  2021cites this paper
• Hepatic Encephalopathy: From Metabolic to Neurodegenerative

  2021cites this paper
• Association of anti-neutrophil cytoplasmic antibody in ischemic stroke Egyptian patients with hepatitis C virus.

  2021cites this paper
• Neurological and psychiatric effects of hepatitis C virus infection

  2021cites this paper
• Impact of direct acting antivirals (DAA) on neurologic disorders in chronic hepatitis C.

  2021cites this paper
• Peripheral artery disease and physical function in women with and without HIV

  2021cites this paper
• Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway

  2021cites this paper
• Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders

  2021influential citation
• Characteristics of Palmar Aponeurosis in Patients with Dupuytren’s Contracture and Viral Hepatitis

  2021cites this paper
• Peculiarities of the Expression of Immunohistochemical Marker HCV nS3 in the Autopsy Brain of the Patients Died in the Outcome of Chronic Infection, Caused by Hepatitis C Virus

  2020cites this paper
• Patient-Reported Satisfaction and Associated Changes in Health and Behavior Pre- and Post- Project INSPIRE: a Comprehensive Hepatitis C Care Coordination Program

  2020cites this paper
• Can we offer more for cognitive impairment in patients with chronic hepatitis C?

  2020cites this paper
• Pain related viral infections: a literature review

  2020cites this paper
• High‐Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A Pilot Study in Egyptian Patients.

  2020cites this paper
• Association between viral hepatitis infection and Parkinson's disease: A population‐based prospective study

  2020cites this paper
• Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life

  2019cites this paper
• Infection with hepatitis C virus as a cause of nervous system disorders

  2019cites this paper
• La peau comme fenêtre du système nerveux : physiopathologie et biomarqueurs

  2019cites this paper
• Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case report

  2019cites this paper
• Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders.

  2019cites this paper
• Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

  2019cites this paper
• Serum lipid profile, liver function indices and electrolyte levels in diabetics and subjects with hepatic impairment in the University of Port Harcourt Teaching Hospital

  2019cites this paper
• Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.

  2019cites this paper
• Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.

  2019cites this paper
• Neurocognitive Impairments and Depression and Their Relationship to Hepatitis C Virus Infection

  2018cites this paper
• Impact of Direct Acting Antiviral Drugs (DAADs) on Cognitive function among Hepatitis C Virus Infected Patients

  2018cites this paper
• S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood–Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder

  2018cites this paper
• Belief in God’s Help During Hepatitis C: A Qualitative Study on Muslim Patients in Pakistan

  2018cites this paper
• Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C

  2018cites this paper
• Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study

  2018cites this paper
• The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity

  2018cites this paper
• Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation

  2018cites this paper
• Carpal tunnel syndrome in HIV-positive patients coinfected with HCV.

  2017cites this paper
• A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis.

  2017cites this paper
• The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART)

  2017cites this paper
• Current HIV Prevention Policies Are Jeopardizing the “End of AIDS” Project: Realities Counteract Liberal Visions

  2017cites this paper
• Hepatitis C and HIV Neurological Implications

  2017cites this paper
• Chronic Hepatitis C Virus Infection and Depression.

  2017cites this paper
• Neuropathological and Neuropsychiatric Determinants in HCV- Infected Patients

  2017influential citation
• Peripheral neuropathy is not the end but the beginning

  2017cites this paper
• International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement.

  2016influential citation
• World Journal of Gastroenterology

  year unknowncites this paper